Cardiovascular disease prevention, blood pressure, cholesterol, and heart function
619 artigos
The TIGHT K trial's 6-month follow-up reveals how potassium supplementation thresholds during cardiac surgery recovery affect longer-term outcomes.
A JAMA review synthesizes evidence showing CRT significantly reduces mortality and hospitalizations in heart failure patients with electrical dyssynchrony.
A Harvard-affiliated clinician challenges assumptions about when defibrillation is truly advised in cardiac emergencies.
A 330-patient multicenter RCT tests whether thymosin α1 can curb immune dysregulation and organ dysfunction after acute type A aortic dissection repair.
Children with sepsis and elevated procalcitonin show measurable microvascular dysfunction, higher organ failure rates, and increased mortality.
Major cardiology societies overhaul training requirements for cardiac electrophysiology fellows, reflecting a decade of advances in arrhythmia care.
A 160-patient RCT shows LBBP dramatically reduces pacing-induced cardiomyopathy and preserves heart function over 3 years.
A 965-patient RCT shows omitting defibrillation testing during subcutaneous ICD implantation is non-inferior to routine testing when device position is scored by chest X-ray.
A longevity-linked protein blocks two key mechanisms of doxorubicin heart damage, offering a potential cardioprotective strategy for cancer patients.
A protein linked to cardiovascular protection predicts mitral valve deterioration and heart failure risk after STEMI, opening a new prognostic window.
New evidence suggests oral semaglutide sustains long-term improvements in key CVD risk factors, expanding its role beyond diabetes management.
A landmark AHA statement challenges decades of blanket activity restrictions for children with cardiomyopathy, offering new risk-stratified guidance.
